Sanofi Pasteur, the vaccines division of Sanofi, announced today that its initial doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza, or flu season have actually been released by the U.S. Meals and Drug Administration (FDA) for shipment.
Sanofi Pasteur’s Fluzone® High-Dose (Influenza Vaccine)
This represents the initial of a lot more compared to 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will certainly be delivered to U.S. good health care providers and pharmacies start in July and continuing throughout the remainder of the year. Sanofi Pasteur strategies to enhance its supply to respond to the shifting pediatric public good health needs.
Seasonal influenza task commonly occurs in between October and Could and peaks in between December and February. However, influenza task peaked noticeably late last season occurring in very early March 2016. Influenza seasons are constantly unpredictable as brand-new influenza strains emerge and strain task fluctuates throughout the year, making timely vaccination more essential to guidance protect versus the virus, especially for seniors, young kids and babies 6 months of age and older.
The Centers for Ailment Regulate and Prevention (CDC) recommends annual influenza vaccination for everybody 6 months of age and older, along with rare exception, and recommends receiving the vaccine as quickly as it is offered to guidance along with prevention also prior to the season begins. In the 2015-2016 influenza season, 50 percent of seniors that were vaccinated received Fluzone High-Dose vaccine, and this number is expected to rise to 60 percent in the coming season.
“There is overall awareness of influenza among the public offered its prevalent prevalence,” said David P. Greenberg, M.D., Associate Vice President and Local Medical Head North America, Sanofi Pasteur. “What is not populared is that influenza can easily be life-threatening and have actually a enduring good health impact, especially for the many vulnerable populations. In the 2014-2015 season, the CDC estimated 40 million flu illnesses, 19 million flu-associated medical visits and practically 1 million flu-associated hospitalizations.”
Related:
- Yellow fever vaccine: NIH begins early-phase clinical trial
- Increased vaccine acceptance reported by good health professionals, yet hesitancy & refusal continue to be problematic; Survey
- Southern California: Meningitis vaccine tips expanded to contain every one of MSM
Tags: 2016-2017 flu season, flu season, flu shots, flu vaccine, Fluzone, influenza, influenza vaccine, Sanofi Pasteur
from Influenza – NewsBlog http://ift.tt/2aeuo2N
